Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Neurol ; 166(1): 190-5, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11031095

ABSTRACT

We investigated the role of tumor necrosis factor (TNF)-alpha in the onset of neuronal and glial apoptosis after traumatic spinal cord crush injury in rats. A few TUNEL-positive cells were first observed within and surrounding the lesion area 4 h after injury, with the largest number observed 24-48 h after injury. Double-labeling of cells using cell type-specific markers revealed that TUNEL-positive cells were either neurons or oligodendrocytes. One hour after injury, an intense immunoreactivity to TNF-alpha was observed in neurons and glial cells in the lesion area, but also seen in cells several mm from the lesion site rostrally and caudally. The level of nitric oxide (NO) also significantly increased in the spinal cord 4 h after injury. The injection of a neutralizing antibody against TNF-alpha into the lesion site several min after injury significantly reduced both the level of NO observed 4 h thereafter as well as the number of apoptotic cells observed 24 h after spinal cord trauma. An inhibitor of nitric oxide synthase (NOS), N(G)-monomethyl-l-arginine acetate (l-NMMA), also reduced the number of apoptotic cells. This reduction of apoptotic cells was associated with a decrease in DNA laddering on agarose gel electrophoresis. These results suggest that: (i) TNF-alpha may function as an external signal initiating apoptosis in neurons and oligodendrocytes after spinal cord injury; and (ii) TNF-alpha-initiated apoptosis may be mediated in part by NO as produced by a NOS expressed in response to TNF-alpha.


Subject(s)
Apoptosis/physiology , Nerve Degeneration/physiopathology , Neuroglia/metabolism , Spinal Cord Injuries/physiopathology , Tumor Necrosis Factor-alpha/metabolism , Animals , In Situ Nick-End Labeling , Male , Nerve Degeneration/immunology , Nerve Degeneration/pathology , Neuroglia/immunology , Neuroglia/pathology , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction/physiology , Spinal Cord Injuries/immunology , Spinal Cord Injuries/pathology , Tumor Necrosis Factor-alpha/immunology
2.
Pharm Res ; 17(3): 314-20, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10801220

ABSTRACT

PURPOSE: To develop a non-viral gene delivery system in the form of an oil-in-water (o/w) lipid emulsion. METHOD: Cationic lipid emulsions were formulated with soybean oil, 1,2-dioleoyl-sn-glycero-3-trimethylammonium-propane (DOTAP) as a cationic emulsifier and other co-emulsifiers. The physical characteristics of the lipid emulsion and the emulsion/DNA complex were determined. The in vitro transfection efficiency of the emulsion/DNA complex was determined in the presence of up to 90% serum. RESULTS: The average droplet size and zeta potential of emulsions were ca. 180 nm and ca. +50 mV, respectively. Among the emulsions, a stable formulation was selected to form a complex with a plasmid DNA encoding chloramphenicol acetyltransferase. By increasing the ratio of emulsion to DNA. zeta-potential of the emulsion/DNA complex increased monotonously from negative to positive without any changes in the complex size. The complex was stable against DNase I digestion and an anionic poly-L-aspartic acid (PLAA). The complex delivered DNA into the cells successfully, and the transfection efficiency was not affected by complex formation time from 20 min to 2 h. More importantly, the cationic lipid emulsion facilitated the transfer of DNA in the presence of up to 90% serum. CONCLUSIONS: The cationic lipid emulsion/DNA complex has physical stability and serum resistant properties for gene transfer.


Subject(s)
Blood Proteins/pharmacology , Gene Transfer Techniques , Plasmids , Polyethylene Glycols/pharmacokinetics , Soybean Oil/pharmacokinetics , Animals , Biological Transport/drug effects , COS Cells , Cations/pharmacokinetics , Choline O-Acetyltransferase/genetics , Deoxyribonucleases , Electrophoresis , Emulsions , Glycerol/pharmacokinetics , Peptides , Transfection , Water
SELECTION OF CITATIONS
SEARCH DETAIL
...